Tracking Biological Aging in Clinical Settings

AI Tool Predicts Cancer Survival via Face Photos

Mass General Brigham researchers develop FaceAge to track biological aging as a non-invasive prognostic biomarker.

By Avantgarde News Desk··1 min read
A digital screen shows a human face scan with geometric data overlays used for biological age estimation in a medical research lab.

A digital screen shows a human face scan with geometric data overlays used for biological age estimation in a medical research lab.

Photo: Avantgarde News

Researchers at Mass General Brigham introduced FaceAge, an artificial intelligence tool that calculates biological age using facial photographs [1]. The study demonstrates that monitoring how quickly a face ages over time can act as a non-invasive biomarker to predict survival outcomes for individuals with cancer [1][2]. This technology offers a potentially cost-effective way to assess patient health without invasive procedures [2].

The AI-driven system analyzes specific facial features to determine if a patient is aging faster than their chronological age [1]. While medical research often focuses on specific diseases like pancreatic cancer, tools like FaceAge look at broader systemic health indicators [3]. Scientists believe this prognostic tool could help clinicians tailor treatments based on a patient's biological resilience [1][2].

Editorial notes

Transparency note

AI assisted drafting. Human edited and reviewed.

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

Low

Reviewed for sourcing quality and editorial consistency.

Sources

Related stories

View all

Topics

Get the weekly briefing

Weekly brief with top stories and market-moving news.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Avantgarde News Desk covers tracking biological aging in clinical settings and editorial analysis for Avantgarde News.